Clik here to view.
Bionic pancreas dev Bigfoot Biomedical reels in $2.4m
Bionic pancreas developer Bigfoot Biomedical raised $2.4 million in a new round of debt financing, according to an SEC filing posted yesterday. The company, while staying mostly under the radar, is...
View ArticleClik here to view.
Contego touts post-market data for Paladin balloon
Contego Medical today released preliminary data from a post-market registry study of its Paladin carotid post-dilation balloon that showed improved patient outcomes in individuals treated with the...
View ArticleClik here to view.
Polyganics wins FDA 510(k) for Neurocap
Polyganics said today it won FDA 510(k) clearance for its Neurocap device, designed to reduce neuroma formation and facilitate tissue repair. Neuromas, also known as pinched nerves or nerve tumors,...
View ArticleClik here to view.
Sanders joins Markey, puts hold on FDA chief nominee Califf
U.S. Democratic presidential candidate Bernie Sanders placed a hold on Barack Obama’s FDA nominee Robert Califf, stating Califf is too close to the pharma industry to be an impartial regulator....
View ArticleClik here to view.
LifeImage picks up mammography medical exchange network Mammosphere
LifeImage said today it picked up national mammography and women’s imaging medical exchange network Mammosphere for an undisclosed amount. The acquisition will open up Mammosphere’s existing network,...
View ArticleClik here to view.
ACT touts 1st-in-human trial for RF ablation tech
Advanced Cardiac Therapeutics said yesterday the 1st 12 patients have been treated using its open-irrigated radio frequency ablation technology to treat atrial fibrillation. The treatments were...
View ArticleClik here to view.
Grisham inks medical novel focused on focused ultrasound; Calls it “most...
Bestselling author John Grisham has stepped out of the legal thriller genre to write The Tumor, a fictional tale centering around a very real medical technology: focused ultrasound. The book follows a...
View ArticleClik here to view.
Boston Scientific sells Boston area warehouse to FedEx
Boston Scientific has sold 1 of its 2 North Quincy warehouses to FedEx, but will rent it from the shipping company through next year. The Marlborough, Mass.-based company said that despite having 2...
View ArticleClik here to view.
Stryker’s Q4 beats The Street
Stryker (NYSE:SYK) beat the consensus forecast on Wall Street with its 4th-quarter and full-year results, sales and earnings, sending share prices up today in late trading. The Kalamazoo, Mich.-based...
View ArticleClik here to view.
In brief: Brazil’s ANVISA recognizes second MDSAP auditor
By Stewart Eisenhart, Emergo Group Brazilian medical device market regulator ANVISA has named a second firm, TÜV SÜD America, as an accredit audit organization under the international Medical Device...
View ArticleClik here to view.
Judge boots Boston Scientific counterfeit mesh case to the FDA
A federal judge yesterday booted a purported class-action racketeering lawsuit filed against Boston Scientific (NYSE:BSX), accusing the medical device maker of illegally smuggling counterfeit resin...
View ArticleClik here to view.
Bidding war heats up for Toshiba Medical
A bidding war for Toshiba (TYO:6502) subsidiary Toshiba Medical is reportedly heating up among a slew of private equity players and rival corporations. Toshiba, which said last month that it’s seeking...
View ArticleClik here to view.
St. Jude Medical’s Q4 profits cut in half
Fourth-quarter profits for St. Jude Medical (NYSE:STJ) were off more than 50%, the medical device company said today, as its $3 billion acquisition of Thoratec put a $179 million hit on the bottom...
View ArticleClik here to view.
Stryker CFO Jellison retires, Boehnlein steps up | Personnel Moves
Stryker (NYSE:SYK) said yesterday that CFO and veep William Jellison is retiring, and will be replaced by former medsurg & neurotechnology group CFO Glenn Boehnlein. The Kalamazoo, Mich.-based...
View ArticleClik here to view.
Nuo Therapeutics files for bankruptcy
Wound care company Nuo Therapeutics (OTC:NUOT) said yesterday that it’s declaring Chapter 11 bankruptcy a little more than 2 years after raising $35 million. Formerly known as Cytomedix, Nuo...
View ArticleClik here to view.
Novartis taps Hospira-sale engineer exec Ball to revive slumping Alcon
Novartis (NYSE:NVS) is looking to revitalize its slumping Alcon eye care division by picking up medical vet Michael Ball, who recently organized Hospira’s $15 billion sale to Pfizer (NYSE:PFE). Ball...
View ArticleClik here to view.
TransEnterix surges on takeover speculation
TransEnterix (NYSE:TRXC) shares surged today on speculation that the robot-assisted surgery company could be acquired by Johnson & Johnson (NYSE:JNJ). Johnson & Johnson chairman & CEO said...
View ArticleClik here to view.
Admedus inks exclusive distro deal with Coroneo
Admedus (ASX:AHZ) said today it inked an exclusive distribution agreement with Coroneo to sell its Extra aortic annuloplasty ring ing and other heart valve surgery instruments in Germany and the U.K....
View ArticleClik here to view.
Velano Vascular wins FDA nod for new blood draw device
Velano Vascular said today that it won 510(k) clearance from the FDA for a new iteration of its needle-free blood draw device. San Francisco-based Velano, which raised a $5 million Series A round in...
View ArticleClik here to view.
MEPS Real-Time expands staff, headquarters
RFID inventory management company MEPS Real-Time said it is adding to its sales, marketing, product management and engineering team, as well as expanding its Carlsbad, Calif.-based headquarters nearly...
View Article